KNE fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Kane Biotech, Inc. is a biotechnology company, which engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. It operates through Domestic and International geographical segments. The firm's trademarks include StrixNB, DispersinB, Aledex, bluestem, silkstem, coactiv+, and Kan. The company was founded in 2001 and is headquartered in Winnipeg, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
KNE has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company